| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Alzheimer's Association Update
|
|
|
2013
|
9 |
3 |
p. 360-361
2 p.
|
artikel
|
| 2 |
Alzheimer's disease pathology does not mediate the association between depressive symptoms and subsequent cognitive decline
|
Royall, Donald R.
|
|
2013
|
9 |
3 |
p. 318-325
8 p.
|
artikel
|
| 3 |
Amyloid positron emission tomography with 18F-flutemetamol and structural magnetic resonance imaging in the classification of mild cognitive impairment and Alzheimer’s disease
|
Duara, Ranjan
|
|
2013
|
9 |
3 |
p. 295-301
7 p.
|
artikel
|
| 4 |
A prediction model to calculate probability of Alzheimer’s disease using cerebrospinal fluid biomarkers
|
Spies, Petra E.
|
|
2013
|
9 |
3 |
p. 262-268
7 p.
|
artikel
|
| 5 |
Benefits of combined cholinesterase inhibitor and memantine treatment in moderate–severe Alzheimer's disease
|
Gauthier, Serge
|
|
2013
|
9 |
3 |
p. 326-331
6 p.
|
artikel
|
| 6 |
Cognitive and functional resilience despite molecular evidence of Alzheimer’s disease pathology
|
Negash, Selam
|
|
2013
|
9 |
3 |
p. e89-e95
nvt p.
|
artikel
|
| 7 |
Cognitive correlates of cerebrospinal fluid biomarkers in frontotemporal dementia
|
Koedam, Esther L.G.E.
|
|
2013
|
9 |
3 |
p. 269-275
7 p.
|
artikel
|
| 8 |
Contents
|
|
|
2013
|
9 |
3 |
p. A1-A2
nvt p.
|
artikel
|
| 9 |
CSF biomarker variability in the Alzheimer's Association quality control program
|
Mattsson, Niklas
|
|
2013
|
9 |
3 |
p. 251-261
11 p.
|
artikel
|
| 10 |
Discriminatory and predictive capabilities of enzyme-linked immunosorbent assay and multiplex platforms in a longitudinal Alzheimer’s disease study
|
Jongbloed, Wesley
|
|
2013
|
9 |
3 |
p. 276-283
8 p.
|
artikel
|
| 11 |
Editorial Board
|
|
|
2013
|
9 |
3 |
p. A3-
1 p.
|
artikel
|
| 12 |
Effectiveness of antidementia drugs in delaying Alzheimer's disease progression
|
Rountree, Susan D.
|
|
2013
|
9 |
3 |
p. 338-345
8 p.
|
artikel
|
| 13 |
Homocysteine, progression of ventricular enlargement, and cognitive decline: The Second Manifestations of ARTerial disease-Magnetic Resonance study
|
Jochemsen, Hadassa M.
|
|
2013
|
9 |
3 |
p. 302-309
8 p.
|
artikel
|
| 14 |
Medical and Scientific Advisory Council
|
|
|
2013
|
9 |
3 |
p. A4-
1 p.
|
artikel
|
| 15 |
Mild cognitive impairment in a community sample: The Sydney Memory and Ageing Study
|
Brodaty, Henry
|
|
2013
|
9 |
3 |
p. 310-317.e1
2861 p.
|
artikel
|
| 16 |
Phenotypic regional functional imaging patterns during memory encoding in mild cognitive impairment and Alzheimer's disease
|
Browndyke, Jeffrey N.
|
|
2013
|
9 |
3 |
p. 284-294
11 p.
|
artikel
|
| 17 |
Predictors and outcomes for caregivers of people with mild cognitive impairment: A systematic literature review
|
Seeher, Katrin
|
|
2013
|
9 |
3 |
p. 346-355
10 p.
|
artikel
|
| 18 |
Risk disclosure and preclinical Alzheimer’s disease clinical trial enrollment
|
Grill, Joshua D.
|
|
2013
|
9 |
3 |
p. 356-359.e1
3235 p.
|
artikel
|
| 19 |
Standardization of analysis sets for reporting results from ADNI MRI data
|
Wyman, Bradley T.
|
|
2013
|
9 |
3 |
p. 332-337
6 p.
|
artikel
|
| 20 |
Subscriber information
|
|
|
2013
|
9 |
3 |
p. A5-
1 p.
|
artikel
|
| 21 |
Systematic review of the body of evidence for the use of biomarkers in the diagnosis of dementia
|
Noel-Storr, Anna H.
|
|
2013
|
9 |
3 |
p. e96-e105
nvt p.
|
artikel
|
Tijdschrift beschrijving